Core Viewpoint - Kosen Technology (603626.SH) expects a net loss attributable to shareholders of the parent company ranging from 330 million to 245 million yuan for the year 2025 [1] Group 1: Performance Expectations - The company anticipates a significant net loss for 2025, indicating challenges in achieving profitability [1] - The projected loss reflects a downturn in market demand and lower-than-expected orders, resulting in low capacity utilization [1] Group 2: Reasons for Performance Changes - Market demand fluctuations have led to orders not meeting expectations, contributing to the company's low capacity utilization [1] - Strategic adjustments to optimize low-margin projects have resulted in inventory write-offs and asset impairment losses [1] - Continuous high investment in R&D to enhance product competitiveness has negatively impacted net profit [1]

Core Viewpoint - Kosen Technology (603626) expects a net profit loss attributable to shareholders of the parent company between 245 million and 330 million yuan for the fiscal year 2025 due to market demand fluctuations and lower-than-expected orders [1] Group 1: Financial Performance - The company anticipates a net profit loss of 245 million to 330 million yuan for 2025 [1] - The low capacity utilization rate has contributed to the company's financial challenges [1] Group 2: Strategic Adjustments - The company is undergoing strategic layout adjustments to optimize low-margin projects, which has resulted in inventory write-offs and asset impairment losses [1] - Continuous high investment in R&D to enhance product competitiveness has impacted the company's net profit [1]

Group 1 - The company, Kosen Technology, forecasts a net profit attributable to shareholders of the parent company for 2025 to be between -330 million yuan and -245 million yuan [1] - The decline in profit is attributed to fluctuating market demand, lower-than-expected orders, and low capacity utilization [1] - Strategic adjustments to optimize low-margin projects have led to inventory write-offs and asset impairment losses [1] - Continuous high investment in R&D to enhance product competitiveness has also impacted the company's net profit [1] Group 2 - The news mentions a potential entry of a "cheap version" of the Tesla Model 3 into the Chinese market, with a range of 480 kilometers [1] - There are significant adjustments in the U.S. market regarding autonomous driving [1]

Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -330 million and -245 million yuan[3]. - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -393 million and -308 million yuan[3]. - The previous year's net profit attributable to shareholders was -476.83 million yuan, indicating a significant decline in performance[5]. - The company reported a total profit of -520.22 million yuan for the previous year[5]. Reasons for Performance Decline - The main reasons for the performance decline include market demand fluctuations, lower order volumes, and strategic adjustments leading to inventory write-offs and asset impairment losses[7]. - The company has maintained high R&D expenditures to enhance product competitiveness, impacting net profit[7]. Non-Recurring Gains - Non-recurring gains primarily consist of government subsidies and recoveries from assets of wholly-owned subsidiaries[7]. Caution for Investors - The company emphasizes that the performance forecast is preliminary and has not been audited by certified public accountants[9]. - Investors are advised to be cautious as the final financial data will be disclosed in the audited annual report for 2025[9]. Performance Forecast Period - The performance forecast period is from January 1, 2025, to December 31, 2025[4].

科森科技公告，公司预计2025年年度实现归属于母公司所有者的净利润为-33,000万元到-24,500万元； 公司预计2025年年度实现归属于母公司所有者的扣除非经常性损益后的净利润为-39,300万元到-30,800 万元。报告期内，公司业绩变动的主要原因：一是市场需求波动，订单未达预期，产能利用率处于较低 水平；二是公司进行战略性布局调整，优化低毛利项目，导致库存报废及计提资产减值损失；三是公司 为提升产品竞争力，研发费用持续保持较高投入，对公司净利润产生了一定影响。 ...

格隆汇1月15日丨科森科技(603626.SH)公布，经财务部门初步测算，公司预计2025年年度实现归属于母 公司所有者的净利润为-33,000万元到-24,500万元；公司预计2025年年度实现归属于母公司所有者的扣 除非经常性损益后的净利润为-39,300万元到-30,800万元。 ...

Group 1 - The core viewpoint of the article is that Kosen Technology (603626) has a strong international presence, with its products being exported to various countries including Europe, America, and Southeast Asia [1] Group 2 - The company engages with investors through an interactive platform, indicating a commitment to transparency and communication [1] - The mention of specific regions such as Europe, America, and Southeast Asia highlights the company's strategic focus on diverse markets [1]

Group 1 - The consumer electronics sector increased by 0.16% on January 14, with Kosen Technology leading the gains [1] - The Shanghai Composite Index closed at 4126.09, down 0.31%, while the Shenzhen Component Index closed at 14248.6, up 0.56% [1] - Kosen Technology's stock price rose by 6.31% to 20.88, with a trading volume of 718,100 shares and a transaction value of 1.503 billion yuan [1] Group 2 - The consumer electronics sector experienced a net outflow of 5.741 billion yuan from institutional investors, while retail investors saw a net inflow of 4.997 billion yuan [2] - The top stocks with significant net inflows from retail investors included Kosen Technology, with a net inflow of 13.5 million yuan, and ST Derun, with a net inflow of 43.6 million yuan [3] - The overall trading activity in the consumer electronics sector showed mixed results, with some stocks like Kosen Technology and Victory Precision seeing positive movements, while others like Hongrid and Tonglian Precision faced declines [2][3]

Group 1 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash purchase and capital increase, making Huiru a subsidiary [1] - Huiru Technology specializes in the research, production, and sales of high-performance electrolytic copper foil, including lithium battery copper foil and electronic circuit copper foil [1] Group 2 - Medike's shareholder plans to reduce holdings by no more than 1% of the company's shares, amounting to approximately 410.93 million shares [2] - Huadong Medicine's subsidiary, Daor Biotechnology, has its product DR10624 included in the list of breakthrough therapeutic varieties, targeting severe hypertriglyceridemia [3] Group 3 - Fangsheng Pharmaceutical received a notice of non-compliance from the Hunan Provincial Drug Administration regarding its raw material drug production [4] - Yanjing Co. is planning a major asset restructuring, leading to a temporary suspension of its stock [5] - Xianle Health intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [6] Group 4 - Huate Gas shareholders plan to collectively reduce their holdings by no more than 2% of the company's shares [7] - Hangyu Technology plans to sell up to 752,800 repurchased shares to supplement working capital [8] Group 5 - Sichuan Electronics expects a net loss of between 265 million to 340 million yuan for the year 2025 [10] - Jinzongzi Wine anticipates a net loss for the 2025 fiscal year, although the loss is expected to narrow compared to the previous year [11] - Hebang Bio forecasts a net loss for 2025 due to anticipated asset impairment provisions [12] Group 6 - Dechang Co. expects a net profit decrease of 51% to 61% for 2025, estimating a profit of 160 million to 200 million yuan [13] - Kosen Technology and Weiyuan Co. both project net losses for 2025 [14][15] - Xiantan Co. reported a chicken product sales revenue of 530 million yuan in December 2025, with a year-on-year increase of 9.41% [16] Group 7 - Shangluo Electronics' application for issuing convertible bonds has been accepted by the Shenzhen Stock Exchange [17] - Zhongheng Group anticipates a net loss for 2025 [18]

Core Viewpoint - The company, Kunshan Kosen Technology Co., Ltd., anticipates a net loss for the fiscal year 2025, primarily due to market demand fluctuations, strategic adjustments, and high R&D expenditures [1] Group 1: Financial Performance - The company expects a negative net profit attributable to shareholders for the year 2025 [1] - The anticipated loss is attributed to lower-than-expected orders and low capacity utilization [1] - The company is in communication with its annual audit accountant regarding the performance forecast, with no significant disagreements reported [1] Group 2: Strategic Adjustments - The company is undergoing strategic layout adjustments to optimize low-margin projects, which has resulted in inventory write-offs and asset impairment losses [1] - Continuous high investment in R&D is aimed at enhancing product competitiveness, impacting net profit [1] Group 3: Compliance and Disclosure - The company commits to adhering to the Shanghai Stock Exchange listing rules and will expedite financial accounting to disclose the 2025 performance forecast promptly [1]